prlb20151009_8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

  

FORM 8-K

  

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF

 

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 9, 2015

  

Proto Labs, Inc.

 

(Exact name of registrant as specified in its charter)

  

Minnesota

 

001-35435

 

41-1939628

(State or other jurisdiction of incorporation)

  

(Commission File Number)

  

(IRS Employer Identification Number)

 

 

 

5540 Pioneer Creek Drive

 Maple Plain, Minnesota

 

55359

(Address of principal executive offices)

  

(Zip Code)

   

 

Registrant’s telephone number, including area code:

  

(763) 479-3680

  

Not Applicable

(Former name or former address, if changed since last report)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 
 
 

  

Item 7.01.     Regulation FD Disclosure.

 

On October 9, 2015, Proto Labs, Inc. (the “Company”) issued a press release announcing it closed on its acquisition of select assets and operations of Alphaform AG. This press release is furnished as Exhibit 99.1 hereto pursuant to Item 7.01 of this Current Report on Form 8-K, and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under Section 18 of the Exchange Act. Furthermore, the information contained in Exhibit 99.1 shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

  

Item 9.01.     Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1

Press release of Proto Labs, Inc. dated October 9, 2015, announcing its acquisition of select assets and operations of Alphaform AG.

  

 

 
 
 

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

   

Proto Labs, Inc.

  
       
       

 

Date:

October 9, 2015

By:

/s/ Victoria M. Holt

  
     

Victoria M. Holt

  
     

President and Chief Executive Officer

  

 

 

 
 
 

 

EXHIBIT INDEX

  

Exhibit

Number

 

Description

  

Manner of Filing

   

 

    

99.1

  

Press release of Proto Labs, Inc. dated October 9, 2015, announcing its acquisition of select assets and operations of Alphaform AG.

  

Filed electronically